Conduit Pharmaceuticals Inc.

13F holders, Q4 2024 (December 31)
1holders
$0.07avg. 13F price*

At the end of Q4 2024, 1 institutions reported holding Conduit Pharmaceuticals Inc. in their 13F filings. The largest holder was SBI Securities Co., Ltd. ($138).

Company
Conduit Pharmaceuticals Inc.
CUSIP
20678X205
Latest filing quarter
Q1 2025

History

Number of 13F holders

010203040 Q4 2024: 1Q4 2024Q1 2025: 33Q1 2025

Total Exit/New Position Q4 2024

No earlier quarter to compare with.

Ownership 1 holders
SBI Securities Co., Ltd. 0.00% — 2,006 $138

"% of holder's portfolio" is CONDUIT PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Conduit Pharmaceuticals Inc. the manager owns.